- Exchanges
- BSE, NSE
- Industry
- Medical Equipment & Supplies
- Issue
- Book building
Molbio Diagnostics IPO
₹1,041.70
+29.08% on listing
Listing-day close · NSE · 17 Aug 2026 · issue price ₹807
Molbio Diagnostics’ ₹940 crore IPO was priced at ₹807 a share. It listed on the NSE on 17 Aug 2026 and closed its first day at ₹1,041.70, up 29.08% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹940 Cr
- Fresh issue
- ₹200 Cr
- Offer for sale
- ₹740 Cr
- Lot size
- 18 shares
- Minimum investment
- ₹14,526
- Face value
- ₹1
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 49.35× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹9,300 Cr
- P/E (post-issue)
- 56.7
- EPS (post-issue)
- ₹14.24
- ROE
- 15.59%
- ROCE
- 17.55%
- EBITDA margin
- 22.56%
- PAT margin
- 11.28%
- Promoter holding
- 44.89% → 41.29%
Financials as of 31 Mar 2026, from the offer documents.
Listing
- Listing date
- 17 Aug 2026
- Issue price
- ₹807
- Open
- ₹980.00
- High
- ₹1,064.75
- Low
- ₹926.35
- Close
- ₹1,041.70
Listing day on the NSE. The close was +29.08% on the issue price.
FAQs
When did the Molbio Diagnostics IPO open and close?
It opened on 10 Aug 2026 and closed on 12 Aug 2026.
What was the Molbio Diagnostics IPO price?
The price band was ₹768–807 a share. The final issue price was ₹807.
What is the lot size and minimum investment?
One lot is 18 shares, ₹14,526 at ₹807 a share. Retail investors apply in whole lots.
How much did Molbio Diagnostics raise?
₹940 crore: ₹200 crore of new shares and ₹740 crore offered by existing shareholders.
How many times was the Molbio Diagnostics IPO subscribed?
49.35 times overall.
How did Molbio Diagnostics list?
It listed on the NSE on 17 Aug 2026 at ₹980.00 and closed the day at ₹1,041.70, up 29.08% on the ₹807 issue price.
Who is the registrar of the Molbio Diagnostics IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app